跳至主要内容
临床试验/NCT03916939
NCT03916939Unknown不适用

Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients

Centre Hospitalier Intercommunal Creteil2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年9月26日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
2
主要终点
Cushman score (0 to 27)

研究概览

简要总结

The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation.

The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions.

Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.

详细描述

The use of osteopathic techniques for facial equilibration decreases the severity of withdrawal symptoms experienced by patients hospitalized in a weekday hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

盲法说明

simulated osteopathy

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age> 18 years
  • Patient hospitalized for a programmed alcohol withdrawal
  • Patient not abstinent with alcohol before hospitalization
  • Signed informed consent

排除标准

  • Minor patient
  • Patient with an addiction other than alcohol (except tobacco and benzodiazepines)
  • Previous participation in the OSTEOOL study

结局指标

主要结局

Cushman score (0 to 27)

时间窗: Day one

comparison between the two groupe of the cushamn socre between 11:30 am and 00:00 pm. questionary for alcohol dependency

次要结局

  • CIWA Ar (Clinicial Institute Withdrawal Assessment - Alcohol Revised) test (0 to 67)(day 0)
  • quality sleep scale (0 to 5)(day 4)
  • quantity of benzodiazepine mg per 24 hours(day 2)
  • CIWA Ar test (0 to 67)(day 4)
  • cardiac frequency (beat per minute)(day 4)
  • quantity of benzodiazepine (mg per 24 hours)(day 4)
  • Cushmamn score (0 to 27)(day 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验